How Analysts Rated Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Last Week?

May 16, 2018 - By Darrin Black

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) LogoInvestors sentiment decreased to 1.25 in Q4 2017. Its down 0.44, from 1.69 in 2017Q3. It fall, as 21 investors sold Ligand Pharmaceuticals Incorporated shares while 86 reduced holdings. 31 funds opened positions while 103 raised stakes. 22.68 million shares or 0.37% less from 22.76 million shares in 2017Q3 were reported.
Mesirow Investment Mgmt holds 1.03% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 106,887 shares. Barclays Public Ltd Com has 4,294 shares for 0% of their portfolio. Moreover, Proshare Ltd Limited Liability Company has 0.01% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 15,625 shares. Hood River Cap Management Ltd Liability has invested 1.41% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Matarin Capital Management Ltd holds 0.51% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 47,662 shares. Moreover, Elk Creek Prtnrs Lc has 1.08% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 134,650 shares. Tower Cap Lc (Trc) reported 0% stake. Convergence Inv Partners Limited Liability Co owns 14,712 shares for 0.27% of their portfolio. Advisory Svcs Networks Ltd Company has 0.01% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Mason Street Advsrs Llc has invested 0.02% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Raymond James & Associates has 0% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 9,471 shares. Fincl Bank Of Montreal Can has 9,922 shares for 0% of their portfolio. Impax Asset Mngmt Ltd Liability invested in 1.38% or 175,520 shares. Johnson Invest Counsel Inc holds 2,141 shares. Trillium Asset Ltd Com accumulated 4,562 shares.

Since December 20, 2017, it had 0 insider purchases, and 13 insider sales for $17.77 million activity. Sabba Stephen L sold $126,956 worth of stock or 925 shares. On Thursday, February 15 HIGGINS JOHN L sold $1.41 million worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 9,000 shares. 5,444 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares with value of $832,824 were sold by FOEHR MATTHEW W. Davis Todd C also sold $2.62M worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Monday, February 26. $529,635 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) was sold by Aryeh Jason on Friday, February 23. LAMATTINA JOHN L also sold $536,604 worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Ratings Coverage

Among 5 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 4 have Buy rating, 1 Sell and 0 Hold. Therefore 80% are positive. Ligand Pharmaceuticals had 7 analyst reports since November 20, 2017 according to SRatingsIntel. Stephens maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Thursday, February 22 with “Buy” rating. Roth Capital maintained the shares of LGND in report on Monday, February 26 with “Buy” rating. As per Wednesday, January 24, the company rating was maintained by H.C. Wainwright. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, March 7. Craig Hallum maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Wednesday, March 7 with “Buy” rating. The firm earned “Buy” rating on Thursday, February 22 by Craig Hallum. The firm has “Sell” rating by Deutsche Bank given on Monday, November 20. Below is a list of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) latest ratings and price target changes.

07/03/2018 Broker: Craig Hallum Rating: Buy New Target: $200.0 Maintain
07/03/2018 Broker: H.C. Wainwright Old Rating: Buy New Rating: Buy Old Target: $170 New Target: $182 Maintain
26/02/2018 Broker: Roth Capital Rating: Buy New Target: $171.0 Maintain
22/02/2018 Broker: Craig Hallum Rating: Buy New Target: $190.0 Maintain
22/02/2018 Broker: Stephens Rating: Buy New Target: $162.0 Maintain
24/01/2018 Broker: H.C. Wainwright Old Rating: Buy New Rating: Buy Old Target: $159 New Target: $170 Maintain
20/11/2017 Broker: Deutsche Bank Old Rating: Hold New Rating: Sell Old Target: $104 Downgrade

The stock increased 1.87% or $3.47 during the last trading session, reaching $188.84. About 183,915 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has risen 53.11% since May 16, 2017 and is uptrending. It has outperformed by 41.56% the S&P500.

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company has market cap of $4.02 billion. The Company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis and Evomela, which are used to treat multiple myeloma; CorMatrix portfolio of vascular, cardiac, and pericardial tissue repair products; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; Carnexiv that is used as replacement therapy for oral carbamazepine formulations; Nexterone, a Captisol-enabled formulation of amiodarone; Noxafil-IV, a Captisol-enabled formulation of posaconazole for IV use; Exemptia for autoimmune diseases; and Vivitra for breast cancer. It has a 356.29 P/E ratio. The companyÂ’s partners programs, which are in clinical development used for the treatment of seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, kidney disease, and others.

More notable recent Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) news were published by: Streetinsider.com which released: “Ligand Pharma (LGND) Tops Q1 EPS by 40c” on May 08, 2018, also Globenewswire.com with their article: “New Research Coverage Highlights Assurant, Williams Partners, Atmos Energy, Nationstar Mortgage, Applied …” published on May 15, 2018, Streetinsider.com published: “Lakewood Capital Sees 50% Downside in Ligand Pharma (LGND)” on April 24, 2018. More interesting news about Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) were released by: Streetinsider.com and their article: “Lakewood Capital Notes New Longs in DWS Group, Hyundai and WestRock (WRK); New Shorts in Ligand Pharma …” published on April 25, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: Valeant Earnings, Lipocine’s FDA Watch, Invivo CFO Departure” with publication date: May 08, 2018.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Science

Deepwater discovery in Mexican Gulf by Shell

Deepwater discovery in Mexican Gulf by Shell

Kelly Oliver

Recently one of the biggest oil companies in the world Shell has made big exploration of deep waters in the Gulf of Mexico. Researching took place 13 miles from Appomattox Shell’s project, which will start its production in the 2019 year, according to previous plans. Receive News & Ratings Via Email - ...

New recycling program for Boise

New recycling program for Boise

Ellis Scott

The new program is called Hefty EnergyBag Program. It was recently announced in Boise. Although it was made for help with recycling, there is confusion and many questions about it. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news ...

Smart countryside as the key to the future

Smart countryside as the key to the future

Edwin Martin

So-called “smart cities” are usually taken as an example of the future for cities. The rise in the capacity for more information can help us to solve problems on the environmental and human scale. It will be possible with saving of energy and traffic regulations. Receive News & Ratings Via Email - ...

Pollution in the real-time observation

Pollution in the real-time observation

Dolores Ford

New technology made in Utah can provide the results of pollution in the real time. It can be used by environmental researchers who want to receive a clear view of toxins in the air. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary ...

The red tape for commercial space flight is cut by Donald Trump

The red tape for commercial space flight is cut by Donald Trump

Darrin Black

Donald Trump, the 45th current president of the USA, wants commercial flight into space get real. He looks for boosting of space flights before it can be done by China. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news ...

Thomas Hertog talks about his collaboration with Stephen Hawking

Thomas Hertog talks about his collaboration with Stephen Hawking

Thomas Roop

Thomas Hertog, the theoretical physicist told the press about his experience from the work with Stephen Hawking, his implication on Hertog’s new ideas, and their collaboration. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with ...

Doubts behind Electromagnetic Drive Space Thruster Impossible from NASA

Doubts behind Electromagnetic Drive Space Thruster Impossible from NASA

Thomas Roop

While NASA celebrates its new creation, some experts believe it can’t work because of simple violations of the third law of Newton. It was called Impossible after it broke this law. However, further experiments show that it could have happened only because of errors in previous tests. Receive News & Ratings Via ...

New species in 2018

New species in 2018

Peter Erickson

ESF names animals, plants, and microbes that were able to survive instead of all predictions. There are big, small, beautiful, and weird. They have different groups, they are different species and even from different kingdoms. They are all united by their ability to survive and be discovered by scientists. Receive News & ...

Small helicopter on Mars

Small helicopter on Mars

Paul Bridgeforth

There will be a new feature for Mars of 2020. This invention is compared to the bold experiment of Wright Brothers almost 117 years ago. While they have shown that people can fly on Earth, the new invention will make flights possible on Mars. Receive News & Ratings Via Email - Enter ...

New El Niño is coming in 2018

New El Niño is coming in 2018

Orlando Souther

It predicts more natural disasters and unexpected weather conditions for the next year. Researchers say that there will be wildfires, droughts, and scorching temps for the next 12 months. Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and ...